Bile-based detection of extrahepatic cholangiocarcinoma with quantitative DNA methylation markers and its high sensitivity

Journal of Molecular Diagnostics

Volumn 14, Issue 3, 2012, Pages 256-263

  Shin, So Hyun ^a   Lee, Kyoungbun ^b   Kim, Baek Hui ^c   Cho, Nam Yun ^a   Jang, Jin Young ^b   Kim, Yong Tae ^b   Kim, Donguk ^d   Jang, Ja June ^b   Kang, Gyeong Hoon ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; TRANSCRIPTION FACTOR RUNX3; TRANSCRIPTION FACTOR TWIST;

ARTICLE; ASSAY; BILE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER SCREENING; CCND2 GENE; CDH13 GENE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOLOGY; DNA MARKER; DNA METHYLATION; EXTRAHEPATIC CHOLANGIOCARCINOMA; GALLBLADDER; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; QUANTITATIVE DIAGNOSIS; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY;

BILE; CHOLANGIOCARCINOMA; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; GALLBLADDER; GENETIC MARKERS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PARAFFIN EMBEDDING; PROMOTER REGIONS, GENETIC; SENSITIVITY AND SPECIFICITY; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84859625271     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2012.01.014     Document Type: Article

References (44)

1. D. Takai, P.A. Jones Comprehensive analysis of CpG islands in human chromosomes 21 and 22 Proc Natl Acad Sci U S A 99 2002 3740 3745
2. T. Hinoue, D.J. Weisenberger, C.P. Lange, H. Shen, H.M. Byun, D. Van Den Berg, S. Malik, F. Pan, H. Noushmehr, C.M. van Dijk, R.A. Tollenaar, P.W. Laird Genome-scale analysis of aberrant DNA methylation in colorectal cancer Genome Res 2011
3. H. Noushmehr, D.J. Weisenberger, K. Diefes, H.S. Phillips, K. Pujara, B.P. Berman, F. Pan, C.E. Pelloski, E.P. Sulman, K.P. Bhat, R.G. Verhaak, K.A. Hoadley, D.N. Hayes, C.M. Perou, H.K. Schmidt, L. Ding, R.K. Wilson, D. Van Den Berg, H. Shen, H. Bengtsson, P. Neuvial, L.M. Cope, J. Buckley, J.G. Herman, S.B. Baylin, P.W. Laird, K. Aldape Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma Cancer Cell 17 2010 510 522
4. L.D. Wood, D.W. Parsons, S. Jones, J. Lin, T. Sjoblom, R.J. Leary, D. Shen, S.M. Boca, T. Barber, J. Ptak, N. Silliman, S. Szabo, Z. Dezso, V. Ustyanksky, T. Nikolskaya, Y. Nikolsky, R. Karchin, P.A. Wilson, J.S. Kaminker, Z. Zhang, R. Croshaw, J. Willis, D. Dawson, M. Shipitsin, J.K. Willson, S. Sukumar, K. Polyak, B.H. Park, C.L. Pethiyagoda, P.V. Pant, D.G. Ballinger, A.B. Sparks, J. Hartigan, D.R. Smith, E. Suh, N. Papadopoulos, P. Buckhaults, S.D. Markowitz, G. Parmigiani, K.W. Kinzler, V.E. Velculescu, B. Vogelstein The genomic landscapes of human breast and colorectal cancers Science 318 2007 1108 1113
5. K.E. Schuebel, W. Chen, L. Cope, S.C. Glockner, H. Suzuki, J.M. Yi, T.A. Chan, L. Van Neste, W. Van Criekinge, S. van den Bosch, M. van Engeland, A.H. Ting, K. Jair, W. Yu, M. Toyota, K. Imai, N. Ahuja, J.G. Herman, S.B. Baylin Comparing the DNA hypermethylome with gene mutations in human colorectal cancer PLoS Genet 3 2007 1709 1723
6. P.A. Jones, S.B. Baylin The fundamental role of epigenetic events in cancer Nat Rev Genet 3 2002 415 428
7. J.F. Costello, M.C. Fruhwald, D.J. Smiraglia, L.J. Rush, G.P. Robertson, X. Gao, F.A. Wright, J.D. Feramisco, P. Peltomaki, J.C. Lang, D.E. Schuller, L. Yu, C.D. Bloomfield, M.A. Caligiuri, A. Yates, R. Nishikawa, H. Su Huang, N.J. Petrelli, X. Zhang, M.S. O'Dorisio, W.A. Held, W.K. Cavenee, C. Plass Aberrant CpG-island methylation has non-random and tumour-type-specific patterns Nat Genet 24 2000 132 138
8. M. Esteller, P.G. Corn, S.B. Baylin, J.G. Herman A gene hypermethylation profile of human cancer Cancer Res 61 2001 3225 3229
9. J.C. Soria, M. Rodriguez, D.D. Liu, J.J. Lee, W.K. Hong, L. Mao Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers Cancer Res 62 2002 351 355
10. C.A. Eads, R.V. Lord, K. Wickramasinghe, T.I. Long, S.K. Kurumboor, L. Bernstein, J.H. Peters, S.R. DeMeester, T.R. DeMeester, K.A. Skinner, P.W. Laird Epigenetic patterns in the progression of esophageal adenocarcinoma Cancer Res 61 2001 3410 3418
11. T. Maekita, K. Nakazawa, M. Mihara, T. Nakajima, K. Yanaoka, M. Iguchi, K. Arii, A. Kaneda, T. Tsukamoto, M. Tatematsu, G. Tamura, D. Saito, T. Sugimura, M. Ichinose, T. Ushijima High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk Clin Cancer Res 12 2006 989 995
12. T. Nakajima, T. Maekita, I. Oda, T. Gotoda, S. Yamamoto, S. Umemura, M. Ichinose, T. Sugimura, T. Ushijima, D. Saito Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers Cancer Epidemiol Biomarkers Prev 15 2006 2317 2321
13. A. Jemal, T. Murray, A. Samuels, A. Ghafoor, E. Ward, M.J. Thun Cancer statistics, 2003 CA Cancer J Clin 53 2003 5 26
14. H.A. Pitt, W.C. Dooley, C.J. Yeo, J.L. Cameron Malignancies of the biliary tree Curr Probl Surg 32 1995 1 90
15. D.E. Henson, J. Albores-Saavedra, D. Corle Carcinoma of the extrahepatic bile ducts Histologic types, stage of disease, grade, and survival rates Cancer 70 1992 1498 1501
16. M.T. Carriaga, D.E. Henson Liver, gallbladder, extrahepatic bile ducts, and pancreas Cancer 75 1995 171 190
17. A.P. Ferrari Junior, D.R. Lichtenstein, A. Slivka, C. Chang, D.L. Carr-Locke Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies Gastrointest Endosc 40 1994 140 145
18. B.R. Kipp, L.M. Stadheim, S.A. Halling, N.L. Pochron, S. Harmsen, D.M. Nagorney, T.J. Sebo, T.M. Therneau, G.J. Gores, P.C. de Groen, T.H. Baron, M.J. Levy, K.C. Halling, L.R. Roberts A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures Am J Gastroenterol 99 2004 1675 1681
19. K. Yamaguchi, K. Nakano, E. Nagai, K. Chijiiwa, M. Kinoshita, M. Ohta, M. Tanaka Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma Hepatogastroenterology 52 2005 713 718
20. P.D. Sturm, E.A. Rauws, R.H. Hruban, E. Caspers, T.B. Ramsoekh, K. Huibregtse, L.A. Noorduyn, G.J. Offerhaus Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis Clin Cancer Res 5 1999 629 635
21. K. Caca, J. Feisthammel, K. Klee, A. Tannapfel, H. Witzigmann, C. Wittekind, J. Mossner, F. Berr Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines Int J Cancer 97 2002 481 488
22. Y.J. Chen, Q.B. Tang, S.Q. Zou Inactivation of RASSF1A, the tumor suppressor gene at 3p21.3 in extrahepatic cholangiocarcinoma World J Gastroenterol 11 2005 1333 1338
23. S.G. Kim, A.O. Chan, T.T. Wu, J.P. Issa, S.R. Hamilton, A. Rashid Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas Gastroenterology 124 2003 1300 1310
24. Y. Koga, Y. Kitajima, A. Miyoshi, K. Sato, K. Kitahara, H. Soejima, K. Miyazaki Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers Ann Surg Oncol 12 2005 354 363
25. T. Ueki, A.W. Hsing, Y.T. Gao, B.S. Wang, M.C. Shen, J. Cheng, J. Deng, J.F. Fraumeni Jr., A. Rashid Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China Clin Cancer Res 10 2004 1717 1725
26. B. Yang, M.G. House, M. Guo, J.G. Herman, D.P. Clark Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma Mod Pathol 18 2005 412 420
27. B.H. Kim, N.Y. Cho, M. Choi, S. Lee, J.J. Jang, G.H. Kang Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas Arch Pathol Lab Med 131 2007 923 930
28. B.H. Kim, N.Y. Cho, S.H. Shin, H.J. Kwon, J.J. Jang, G.H. Kang CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma Virchows Arch 455 2009 343 351
29. D.S. Sandhu, A.M. Shire, L.R. Roberts Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets Liver Int 28 2008 12 27
30. B. Klump, C.J. Hsieh, S. Dette, K. Holzmann, R. Kiebetalich, M. Jung, U. Sinn, M. Ortner, R. Porschen, M. Gregor Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease Clin Cancer Res 9 2003 1773 1778
31. N.Y. Cho, J.H. Kim, K.C. Moon, G.H. Kang Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm Virchows Arch 454 2009 17 23
32. H.S. Lee, B.H. Kim, N.Y. Cho, E.J. Yoo, M. Choi, S.H. Shin, J.J. Jang, K.S. Suh, Y.S. Kim, G.H. Kang Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma Clin Cancer Res 15 2009 812 820
33. G.H. Kang, S. Lee, N.Y. Cho, T. Gandamihardja, T.I. Long, D.J. Weisenberger, M. Campan, P.W. Laird DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis Lab Invest 88 2008 161 170
34. D.J. Weisenberger, K.D. Siegmund, M. Campan, J. Young, T.I. Long, M.A. Faasse, G.H. Kang, M. Widschwendter, D. Weener, D. Buchanan, H. Koh, L. Simms, M. Barker, B. Leggett, J. Levine, M. Kim, A.J. French, S.N. Thibodeau, J. Jass, R. Haile, P.W. Laird CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer Nat Genet 38 2006 787 793
35. S. Ogino, T. Kawasaki, M. Brahmandam, M. Cantor, G.J. Kirkner, D. Spiegelman, G.M. Makrigiorgos, D.J. Weisenberger, P.W. Laird, M. Loda, C.S. Fuchs Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis J Mol Diagn 8 2006 209 217
36. S. Ogino, M. Cantor, T. Kawasaki, M. Brahmandam, G.J. Kirkner, D.J. Weisenberger, M. Campan, P.W. Laird, M. Loda, C.S. Fuchs CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies Gut 55 2006 1000 1006
37. M.A. Parsi, A. Li, C.P. Li, M. Goggins DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease Clin Gastroenterol Hepatol 6 2008 1270 1278
38. C.A. Eads, K.D. Danenberg, K. Kawakami, L.B. Saltz, C. Blake, D. Shibata, P.V. Danenberg, P.W. Laird MethyLight: a high-throughput assay to measure DNA methylation Nucleic Acids Res 28 2000 E32
39. C.S. Furniss, C.J. Marsit, E.A. Houseman, K. Eddy, K.T. Kelsey Line region hypomethylation is associated with lifestyle and differs by human papillomavirus status in head and neck squamous cell carcinomas Cancer Epidemiol Biomarkers Prev 17 2008 966 971
40. I.M. Smith, W.K. Mydlarz, S.K. Mithani, J.A. Califano DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage Int J Cancer 121 2007 1724 1728
41. D. Oka, S. Yamashita, T. Tomioka, Y. Nakanishi, H. Kato, M. Kaminishi, T. Ushijima The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers Cancer 115 2009 3412 3426
42. H. Enokida, H. Shiina, S. Urakami, M. Terashima, T. Ogishima, L.C. Li, M. Kawahara, M. Nakagawa, C.J. Kane, P.R. Carroll, M. Igawa, R. Dahiya Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma Cancer 106 2006 79 86
43. C.J. Marsit, E.A. Houseman, A.R. Schned, M.R. Karagas, K.T. Kelsey Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer Carcinogenesis 28 2007 1745 1751
44. J.Y. Wu, J. Wang, J.C. Lai, Y.W. Cheng, K.T. Yeh, T.C. Wu, C.Y. Chen, H. Lee Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status Ann Surg Oncol 15 2008 3272 3277